eMagin logo neweMagin reported their 3Q 2011 results: the company matched their best quarter ever in revenues ($8.3 million, same as in 3Q 2010) and operating income was $1.6 million. Net income was $4.1 million.

eMagin also updates us that the new deposition machine that was shipped in October 2011 has arrived at their production facility, and they began to install the equipment. They expect it to operate in the first quarter of 2012. This new machine will increase deposition capacity 10-fold and will also improve the yield. The company said during the conference call that the cost of this new machine is $4 million.

The company re-iterated their guidance for 2011 - revenue will be between $29 and $33 million.

Disclosure: the author of this post holds shares in eMagin

Tags:
Cambridge Isotope Laboratories - Deutreated Reagents and High-Purity Gases for OLEDsCambridge Isotope Laboratories - Deutreated Reagents and High-Purity Gases for OLEDs